Conghuan Shen

538 citations
15 papers · 445 indexed · h-index 10
    • MicroRNA in disease regulation 6
    • Cancer-related molecular mechanisms research 3
    • RNA modifications and cancer 2
    • Circular RNAs in diseases 2
    • RNA Research and Splicing 2
    • Liver Disease Diagnosis and Treatment 2
    • Liver Disease and Transplantation 3
    • Hepatocellular Carcinoma Treatment and Prognosis 2

Conghuan Shen

15 papers receiving 443 citations

Peers

Conghuan Shen
Comparison fields: 5 of 77
  • Cancer Research 248
  • Molecular Biology 311
  • Epidemiology 108
  • Physiology 12
  • Hepatology 21
Replace Yiping Dong with:
Yiping Dong China
Qi-Tao Chen China
Song-Mei Liu China
Yanxin Xu China
Longyi Zheng China
Xiangqiong Mo China
Yingji Chen China
Wuping Yang China
Érika Pereira Zambalde Brazil
Conghuan Shen relative to Yiping Dong China Yiping Dong's profile →
Citations per field
00.5×3.1×
Yiping Dong · 1×
Citations per year

Countries citing papers authored by Conghuan Shen

Since Specialization
Citations

This map shows the geographic impact of Conghuan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conghuan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conghuan Shen more than expected).

Fields of papers citing papers by Conghuan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conghuan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conghuan Shen. The network helps show where Conghuan Shen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Conghuan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Conghuan Shen Line = papers co-authored together Conghuan Shen links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 20253
2 202311
3 20229
4 20223
5 202129
6 202115
7 20218
8 202030
9 201813
10 20189
11 201621
12 201517
13
[Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
20141
14 2012164
15 2012112

About Conghuan Shen

Conghuan Shen is a scholar working on Cancer Research, Hepatology and Clinical Biochemistry, having authored 15 papers that have together received 445 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Liver Disease and Transplantation (3 papers), Cancer-related molecular mechanisms research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver Disease Diagnosis and Treatment (2 papers), RNA modifications and cancer (2 papers), Circular RNAs in diseases (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (248 citations), Molecular Biology (311 citations) and Epidemiology (108 citations). Conghuan Shen has collaborated with scholars based in China and United States. Frequent co-authors include Ning Xu, Feng Xue, Jianjun Zhang, Yi Luo, Qiang Xia, Lei Xia, Zhengxin Wang, Lei Xia, Yi Luo and Yifeng Tao.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026